Genome-wide analysis of DNA methylation in canine lymphoma
Project/Area Number |
15K18789
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Veterinary medical science
|
Research Institution | Hokkaido University |
Principal Investigator |
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | DNAメチル化 / エピジェネティクス / リンパ腫 / エピゲノム / 臨床 / 癌 / ゲノム |
Outline of Final Research Achievements |
Next-generation sequencing for 5 canine lymphoma cell lines was found to be quantitative so that 100,000 CpG sites could be analyzed. It also showed clearly difference in DNA methylation patterns between lymphoma cell lines and normal lymphocytes. We identified 1000-4000 hypermethylated and 3000-10000 hypomethylated CpG sites in each cell line. Genes known to be involved in tumor were found to be located close to the CpG sites hypermethylated in the cell lines. The analysis for 24 spontaneous lymphoma cases indicated that DNA methylation pattern could be prognostic factor in canine lymphoma.
|
Report
(3 results)
Research Products
(8 results)
-
[Journal Article] A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome.2017
Author(s)
Kelly AD, Kroeger H, Yamazaki J, Taby R, Neumann F, Yu S, Lee JT, Patel B, Li Y, He R, Liang S, Lu Y, Cesaroni M, Pierce SA, Kornblau SM, Bueso-Ramos CE, Ravandi F, Kantarjian HM, Jelinek J, Issa JP
-
Journal Title
Leukemia
Volume: 印刷中
Issue: 10
Pages: 2011-2019
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] Hypomethylation of TET2 target genes identifies a curable subset of acute myeloid leukemia.2016
Author(s)
Yamazaki J, Taby R, Jelinek J, Raynal NJ, Cesaroni M, Pierce SA, Kornblau SM, Bueso-Ramos CE, Ravandi F, Kantarjian HM, Issa JP
-
Journal Title
J. Natl. Cancer Inst.
Volume: 108
Issue: 2
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer.2016
Author(s)
Tahara T, Shibata T, Okamoto Y, Yamazaki J, Kawamura T, Horiguchi N, Okubo M, Nakano N, Ishizuka T, Nagasaka M, Nakagawa Y, Ohmiya N
-
Journal Title
Oncotarget
Volume: 7
Issue: 27
Pages: 42252-42260
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] TET2 mutations affect non-CpG island DNA methylation at enhancers and transcription factor binding sites in chronic myelomonocytic leukemia.2015
Author(s)
Yamazaki J, Jelinek J, Lu Y, Cesaroni M, Madzo J, Neumann F, He R, Taby R, Vasanthakumar A, Macrae T, Ostler KR, Kantarjian HM, Liang S, Estecio MR, Godley LA, Issa JP
-
Journal Title
Cancer Res.
Volume: 75
Issue: 14
Pages: 2833-43
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features.2015
Author(s)
Malouf GG, Tahara T, Paradis V, Fabre M, Guettier C, Yamazaki J, Long H, Lu Y, Raynal NJ, Jelinek J, Mouawad R, Khayat D, Brugieres L, Raymond E, Issa JP
-
Journal Title
Epigenetics
Volume: 10
Issue: 9
Pages: 872-81
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
-